DK0441955T3 - Fremstilling af biologisk aktiv insulinlignende vækstfaktor I ud fra højekspressionsværtscellesystemer - Google Patents

Fremstilling af biologisk aktiv insulinlignende vækstfaktor I ud fra højekspressionsværtscellesystemer

Info

Publication number
DK0441955T3
DK0441955T3 DK90914315.8T DK90914315T DK0441955T3 DK 0441955 T3 DK0441955 T3 DK 0441955T3 DK 90914315 T DK90914315 T DK 90914315T DK 0441955 T3 DK0441955 T3 DK 0441955T3
Authority
DK
Denmark
Prior art keywords
igf
preparation
host cell
growth factor
biologically active
Prior art date
Application number
DK90914315.8T
Other languages
Danish (da)
English (en)
Inventor
James A Miller
Philip K Hsieh
Larry B Tsai
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0441955T3 publication Critical patent/DK0441955T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90914315.8T 1989-08-25 1990-08-21 Fremstilling af biologisk aktiv insulinlignende vækstfaktor I ud fra højekspressionsværtscellesystemer DK0441955T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/398,699 US5158875A (en) 1989-08-25 1989-08-25 Production of biologically active insulin-like growth factor i from high expression host cell systems

Publications (1)

Publication Number Publication Date
DK0441955T3 true DK0441955T3 (da) 1996-10-07

Family

ID=23576440

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90914315.8T DK0441955T3 (da) 1989-08-25 1990-08-21 Fremstilling af biologisk aktiv insulinlignende vækstfaktor I ud fra højekspressionsværtscellesystemer

Country Status (10)

Country Link
US (1) US5158875A (fr)
EP (1) EP0441955B1 (fr)
JP (1) JPH04501514A (fr)
AT (1) ATE140029T1 (fr)
AU (1) AU644105B2 (fr)
CA (1) CA2023969A1 (fr)
DE (1) DE69027666T2 (fr)
DK (1) DK0441955T3 (fr)
ES (1) ES2089029T3 (fr)
WO (1) WO1991002807A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316932A (en) * 1989-03-24 1994-05-31 Duke University Homogeneous denatured human 06-guanine alkyltransferase prepared by immunoaffinity chromatography using monoclonal antibody specific for enzyme
EP0545999B1 (fr) * 1990-08-20 1997-06-04 Novo Nordisk A/S Procédé de préparation d l'IGF-1 biologiquement actif à partir d'un IGF-1 ayant une extension amino-terminale
US5646016A (en) * 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
US5378613A (en) * 1991-09-24 1995-01-03 Eli Lilly And Company Method for increased expression of low molecular weight recombinant polypeptides
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5958764A (en) * 1992-04-30 1999-09-28 Baylor College Of Medicine Specific expression vectors and methods of use
EP0695359B1 (fr) * 1993-03-29 1997-06-04 E.I. Du Pont De Nemours & Company Incorporated Procede pour augmenter la production de proteines de recombinaison actives sur le plan biologique
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
SE9303784D0 (sv) * 1993-11-16 1993-11-16 Kabi Pharmacia Ab Igf
US5451660A (en) * 1993-12-13 1995-09-19 Genentech, Inc. Method for purifying polypeptides
AU1272295A (en) * 1993-12-17 1995-07-03 Novo Nordisk A/S Proinsulin-like compounds
US5712249A (en) * 1994-09-08 1998-01-27 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
WO1996007744A1 (fr) * 1994-09-08 1996-03-14 Chiron Corporation Procede de production amelioree des facteurs de croissance proches de l'insuline
US5789547A (en) * 1995-06-07 1998-08-04 Celtrix Pharmaceuticals, Inc. Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
CA2396320A1 (fr) * 2000-01-11 2001-07-19 Maxygen, Inc. Systemes integres et procedes associes de production diversifiee et de criblage
WO2008005533A2 (fr) * 2006-07-06 2008-01-10 Aaron Thomas Tabor Compositions et procédés de modification génétique de cellules ayant une fonction cosmétique pour l'amélioration de l'aspect cosmétique
CL2007002502A1 (es) 2006-08-31 2008-05-30 Hoffmann La Roche Variantes del factor de crecimiento similar a insulina-1 humano (igf-1) pegilados en lisina; metodo de produccion; proteina de fusion que la comprende; y su uso para tratar la enfermedad de alzheimer.
EP2059530B1 (fr) * 2006-08-31 2012-08-29 F.Hoffmann-La Roche Ag Procede de production du facteur de croissance i de type insuline (igf-i)
RU2010144014A (ru) * 2008-04-03 2012-05-27 Ф. Хоффманн-Ля Рош Аг (Ch) Применение пегилированных вариантов ифр-i для лечения нейромышечных расстройств
BRPI0911266A2 (pt) * 2008-04-03 2015-09-29 Hoffmann La Roche ensaio de fator de crescimento similar à insulina peguilado
US9132202B2 (en) 2009-07-17 2015-09-15 Aaron T. Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
US20110152188A1 (en) * 2009-12-23 2011-06-23 Hanns-Christian Mahler Pharmaceutical compositions of igf/i proteins
EP3094339B1 (fr) * 2014-01-12 2019-12-11 IGF Oncology, LLC Protéines de fusion contenant un facteur-1 de croissance de type insuline et un facteur de croissance épidermique et leurs variantes
CN112892220B (zh) * 2021-01-19 2023-02-17 南开大学 一种高效的活性蛋白分离方法与装置
CN114292800B (zh) * 2021-12-27 2024-08-20 武汉佰乐博生物技术有限公司 用于igf-1基因重组表达的重组细胞和重组表达方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
FR2594846B1 (fr) * 1986-02-21 1989-10-20 Genetica Procede de preparation de la serum albumine humaine mature
EP0371041A1 (fr) * 1987-06-24 1990-06-06 Novo Nordisk A/S Procede de preparation d'une proteine ou d'un polypeptide, sequence d'adn codant pour le polypeptide, microorganisme contenant la sequence d'adn et le polypeptide et utilisation du polypeptide comme preparation pharmaceutique

Also Published As

Publication number Publication date
DE69027666T2 (de) 1996-11-07
CA2023969A1 (fr) 1991-02-26
ES2089029T3 (es) 1996-10-01
DE69027666D1 (de) 1996-08-08
EP0441955A4 (en) 1992-07-15
US5158875A (en) 1992-10-27
AU644105B2 (en) 1993-12-02
ATE140029T1 (de) 1996-07-15
AU6425490A (en) 1991-04-03
WO1991002807A1 (fr) 1991-03-07
JPH04501514A (ja) 1992-03-19
EP0441955A1 (fr) 1991-08-21
EP0441955B1 (fr) 1996-07-03

Similar Documents

Publication Publication Date Title
DK0441955T3 (da) Fremstilling af biologisk aktiv insulinlignende vækstfaktor I ud fra højekspressionsværtscellesystemer
VAN WYK et al. Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins
SE465222C5 (sv) Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
ATE154641T1 (de) Neues physiologisch aktives schweinepeptid (cnp- 53)
EA199700329A1 (ru) Новый белок и способ его получения
DE3750197D1 (de) Antagonisten des Fibroblasten-Wachstumsfaktors.
ATE123949T1 (de) B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
EP0722461A4 (fr) Expression de polypeptides de fusion transportes hors du cytoplasme sans sequence de tete
ATE264872T1 (de) Mit rekombinantem insulin-ähnlichen wachstumsfaktor igf-i vergleichbare rückfaltung von polypeptiden
DE69132275D1 (de) Beta-type ähnlicher transformierender wachstumfaktor
ES2147558T3 (es) Nuevos polipeptidos para promover la fijacion celular.
DE69126487D1 (de) cDNA für Ratten C-Typ natriuretisches Peptid und Vorläuferprotein
ATE297461T1 (de) Reguliertes autokrines wachstum von säugerzellen
PT99313A (pt) Processo para a preparacao de proteinas, de viros recombinantes e de vectores de transferencia uteis para a expressao dessas proteinas
ATE208816T1 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
ATE108458T1 (de) Immunglobulin-e-kompetitor.
ES2091237T3 (es) Nuevo procedimiento para la produccion de proteina no fusionada en e. coli.
EA200101161A1 (ru) Способ получения рекомбинантного инсулина из новых гибридных белков
DK0467839T3 (da) In-vitro-behandling af fusionsproteiner
KR880701073A (ko) 제조합 dna 기법에 의해 생성된 민악티빈
EA200001252A1 (ru) КОМПОЗИЦИЯ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА-β-1A(IFN-β-1A) ЧЕЛОВЕКА
US7589063B2 (en) Molecules which promote hematopoiesis
Stepanik et al. Primary structure of human alpha 2-macroglobulin. III. Primary structure of three large disulfide-bridged CNBr fragments, located in the COOH-terminal part of alpha 2-macroglobulin and accounting for 301 residues.
KR890013177A (ko) 신규폴리펩티드 및 그것을 코우드하는 dna